Jobs at Kyverna Therapeutics

The Associate Director will lead SEC reporting, technical accounting, and SOX compliance, ensuring timely filings and guiding cross-functional teams in complex accounting matters.

The Sr. Director, Clinical Scientist leads clinical research for Multiple Sclerosis therapies, overseeing study execution, protocol development, and cross-functional collaboration in a biotech setting.

The VP of Commercial Operations will lead and build commercial infrastructure, manage sales field operations, and oversee analytics for cell therapies targeting autoimmune diseases. They will collaborate with cross-functional teams to ensure effective commercialization and launch of products, while developing a high-performing operations team.

The role focuses on evaluating and advising on CAR T technologies and immune cell engineering for autoimmune diseases, conducting scientific assessments, and liaising with internal and external stakeholders.

The Associate Director of Clinical Data Management oversees data management activities for clinical studies, ensuring regulatory compliance and data accuracy from start-up to database lock.

The Executive Director, Regulatory Affairs will lead regulatory strategy for cell therapies, overseeing submissions, health authority engagement, and team development, ensuring commercial readiness and compliance.

The Executive Director, Clinical Data Management leads the data management strategy, ensuring quality clinical data and compliance throughout the clinical development lifecycle.

The Senior Clinical Research Scientist will design, execute, and analyze clinical studies, ensuring compliance with GCP and regulatory requirements, and collaborate across multiple departments.

The Executive Director will optimize and manage Kyverna's supply chain function, oversee supplier selection, negotiate contracts, and lead strategic sourcing efforts across multiple regions to support business growth in cell therapy.

The Sr. Director of Business Development will drive Kyverna's growth strategy through strategic partnerships, licensing, and collaboration in the biopharmaceutical sector.